FDA approves first-of-its-kind drug rusfertide for polycythemia vera
FDA approves first-of-its-kind drug rusfertide for polycythemia vera The Cancer Letter
September 2026
Scholar Rock wins FDA approval for first drug to target SMA muscle loss
Scholar Rock wins FDA approval for first drug to target SMA muscle loss STAT
FDA Approves Apitegromab for Spinal Muscular Atrophy
FDA Approves Apitegromab for Spinal Muscular Atrophy NeurologyLive